Published in BMC Med on January 20, 2012
Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension. Hypertension (2012) 1.03
Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochem Med (Zagreb) (2013) 0.91
Impact of observation on disposition of elderly patients presenting to emergency departments with non-specific complaints. PLoS One (2014) 0.84
Hyponatremia in patients with heart failure. World J Cardiol (2013) 0.84
Predictors of mortality for nursing home-acquired pneumonia: a systematic review. Biomed Res Int (2015) 0.83
Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care (2013) 0.83
Prognostic role of copeptin after stroke: A systematic review and meta-analysis of observational studies. Sci Rep (2015) 0.82
Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury. PLoS One (2015) 0.80
Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein. PLoS One (2013) 0.78
Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study. Neurol Sci (2013) 0.78
Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev (2015) 0.78
Hyponatremia and anti-diuretic hormone in Legionnaires' disease. BMC Infect Dis (2013) 0.78
ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU. Ann Intensive Care (2014) 0.78
Clinical relevance of different biomarkers in imported plasmodium falciparum malaria in adults: a case control study. Malar J (2013) 0.77
The 90-day prognostic value of copeptin in acute intracerebral hemorrhage. Neurol Sci (2014) 0.77
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
Copeptin as a serum biomarker of febrile seizures. PLoS One (2015) 0.75
Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model. Sci Rep (2016) 0.75
Copeptin under glucagon stimulation. Endocrine (2015) 0.75
Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis. Ther Clin Risk Manag (2017) 0.75
Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation. BMJ Open (2014) 0.75
Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina. Dis Markers (2014) 0.75
Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial. Exp Ther Med (2017) 0.75
Biomarkers in acute coronary artery disease. Wien Med Wochenschr (2012) 0.75
The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin. J Biomark (2017) 0.75
Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PLoS One (2017) 0.75
Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med (2009) 8.05
Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med (2009) 6.62
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet (2004) 5.49
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem (2005) 3.55
Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med (2002) 3.50
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature (1982) 2.54
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature (1982) 2.31
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol (2010) 2.25
The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med (2007) 1.92
Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol (2007) 1.92
Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol (2010) 1.75
Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol (2009) 1.73
Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol (2009) 1.71
Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest (2007) 1.64
Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature (1983) 1.64
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation (2007) 1.59
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides (2005) 1.57
Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock (2007) 1.57
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J (2009) 1.48
High-sensitivity cardiac troponin: hype, help, and reality. Clin Chem (2009) 1.48
Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett (2008) 1.48
Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest (2007) 1.45
Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology (1983) 1.38
Vasopressin receptors. Trends Endocrinol Metab (2000) 1.26
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest (2006) 1.23
Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab (2007) 1.18
Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke (2010) 1.17
Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 1.15
Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab (2008) 1.13
Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol (2010) 1.11
Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond) (2009) 1.11
Patients presenting to the emergency department with non-specific complaints: the Basel Non-specific Complaints (BANC) study. Acad Emerg Med (2010) 1.10
Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. Clin Chem (2011) 1.08
Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA (2011) 1.06
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail (2011) 1.05
Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med (2011) 0.97
Hyponatremia in critically ill patients. J Intensive Care Med (2004) 0.95
Weakness as presenting symptom in the emergency department. Swiss Med Wkly (2009) 0.94
Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology (2011) 0.94
Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab (2011) 0.94
Copeptin is associated with mortality in patients with traumatic brain injury. J Trauma (2011) 0.90
The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. Endocrinology (1997) 0.89
Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail (2011) 0.86
Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med (2011) 0.84
The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases. Swiss Med Wkly (2011) 0.84
The hypothalamic-pituitary-adrenal axis in critical illness. Endocrinol Metab Clin North Am (2006) 0.83
Augmentation of the response to CRF in man: relative contributions of endogenous angiotensin and vasopressin. Clin Endocrinol (Oxf) (1985) 0.80
Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med (2009) 8.05
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA (2009) 5.52
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet (2004) 5.49
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA (2013) 4.33
Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest (2007) 4.21
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med (2006) 4.15
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet (2009) 3.81
Modern triage in the emergency department. Dtsch Arztebl Int (2010) 2.73
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol (2010) 2.25
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis (2007) 2.11
Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med (2007) 2.06
The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med (2007) 1.92
Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab (2006) 1.92
The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med (2009) 1.85
Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol (2010) 1.77
Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol (2009) 1.73
Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol (2009) 1.71
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care (2006) 1.70
Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest (2007) 1.64
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation (2007) 1.59
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides (2005) 1.57
Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol (2010) 1.55
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care (2005) 1.49
Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Med Wkly (2006) 1.49
San Francisco Syncope Rule to predict short-term serious outcomes: a systematic review. CMAJ (2011) 1.48
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol (2012) 1.44
Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Ann Emerg Med (2010) 1.44
Plasma copeptin and the risk of diabetes mellitus. Circulation (2010) 1.44
Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab (2007) 1.39
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care (2008) 1.32
Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides (2004) 1.32
Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. J Clin Endocrinol Metab (2011) 1.31
Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem (2006) 1.30
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol (2008) 1.27
New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol (2008) 1.24
Ipsilateral reexpansion pulmonary edema after drainage of a spontaneous pneumothorax: a case report. J Med Case Rep (2007) 1.22
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest (2008) 1.20
Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab (2006) 1.19
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.18
Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab (2007) 1.18
Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke (2010) 1.17
Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care (2010) 1.17
At risk of undertriage? Testing the performance and accuracy of the emergency severity index in older emergency department patients. Ann Emerg Med (2012) 1.16
Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 1.15
Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab (2008) 1.13
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol (2013) 1.13
Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol (2010) 1.11
Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab (2009) 1.11
Patients presenting to the emergency department with non-specific complaints: the Basel Non-specific Complaints (BANC) study. Acad Emerg Med (2010) 1.10
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol (2008) 1.08
The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care (2007) 1.07
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail (2011) 1.05
Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med (2008) 1.04
Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease. Am J Respir Crit Care Med (2008) 1.03
Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study. J Am Geriatr Soc (2015) 1.03
Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One (2011) 1.03
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail (2010) 1.02
Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol (2004) 1.02
Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission. Clin Endocrinol (Oxf) (2007) 1.01
Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS One (2012) 1.01
Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol (2011) 1.01
Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest (2008) 1.00
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm Pharmacol Ther (2004) 1.00
Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab (2011) 1.00
C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction. J Card Fail (2008) 1.00
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients. Eur J Heart Fail (2009) 0.99
Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium (2007) 0.99
Physician's first clinical impression of emergency department patients with nonspecific complaints is associated with morbidity and mortality. Medicine (Baltimore) (2015) 0.98
Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab (2011) 0.98
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. PLoS One (2011) 0.97
Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med (2011) 0.97
Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab (2005) 0.95
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. Biol Psychiatry (2009) 0.93
Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. J Am Coll Cardiol (2009) 0.93
High copeptin concentrations in umbilical cord blood after vaginal delivery and birth acidosis. J Clin Endocrinol Metab (2010) 0.93
Autoantibodies to the IGF1 receptor in Graves' orbitopathy. J Clin Endocrinol Metab (2012) 0.93
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail (2012) 0.93
Copeptin and risk stratification in patients with acute dyspnea. Crit Care (2010) 0.91
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide. Biol Psychiatry (2005) 0.91
State of Emergency Medicine in Switzerland: a national profile of emergency departments in 2006. Int J Emerg Med (2013) 0.91
Effect and clinical prediction of worsening renal function in acute decompensated heart failure. Am J Cardiol (2011) 0.91
A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections. Am J Med (2012) 0.90
Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study. BMC Infect Dis (2007) 0.89
Release of the mitochondrial enzyme carbamoyl phosphate synthase under septic conditions. Shock (2005) 0.89
C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Am Heart J (2007) 0.89
Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients. J Clin Endocrinol Metab (2006) 0.88
Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring) (2009) 0.88
Correlates of diagnostic accuracy in patients with nonspecific complaints. Med Decis Making (2013) 0.88
Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease. Int J Cardiol (2012) 0.88
Proteolytic processing pattern of the endothelin-1 precursor in vivo. Peptides (2005) 0.88